drugset / Trial / NCT00169624
Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin
RandomizedCrossoverDouble-blind
Summary
Peripheral and coronary endothelial dysfunction in type 2 diabetic patients may be influenced by therapeutics. Using Radial flow monitoring and myocardial perfusion magnetic resonance imaging, we designed a controlled randomized double blind study to test the hypothesis that endothelial dysfunction will be reversed following 3 months of Metformin administration vs gliclazide. 30 patients will be included.
Timeline
- Start
- 2005-10
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gliclazide | Small molecule | — | — |
| Subject | Metformin | Small molecule | — | — |
Indications
No indication recorded.